<unk>  <unk>  is a nerve-damaging side effect of antineoplastic agents in the common cancer treatment,<unk> .<unk>  afflicts between 30% and 40% of patients undergoing<unk> . Antineoplastic agents in<unk>  are designed to eliminate rapidly dividing cancer cells, but they can also damage healthy structures, including the<unk>  nervous system.<unk>  involves various symptoms such as tingling, pain, and numbness in the hands and feet. These symptoms can impair activities of daily living, such as typing or dressing, reduce balance, and increase risk of falls and hospitalizations. They can also give cause to reduce or discontinue<unk> . Researchers have conducted clinical trials and studies to uncover the various symptoms, causes, pathogenesis, diagnoses, risk factors, and treatments of<unk> .
Chemotherapy-induced peripheral neuropathy
Diabetic neuropathy
Tropical neuropathy
Progressive inflammatory neuropathy
Vasculitic neuropathy
Small fiber peripheral neuropathy
Alcoholic polyneuropathy
Chronic inflammatory demyelinating polyneuropathy